Clinical Cancer Bulletin
Springer Nature · Singapore
eISSN2791-3937
✓ DOAJ✓ Open Access
15
/ 100
High Risk
Score Breakdown
✓ DOAJ Verified+15
Total15
Aims & Scope✦ Inferred from recent articles
This journal focuses on advancements in cancer treatment and diagnosis, with a particular emphasis on immunotherapies like CAR-T cell therapy and tumor-infiltrating lymphocyte therapy, as well as AI-driven drug design and diagnostic techniques such as ultrasound-guided biopsies and liquid biopsies. The scope also includes research on specific cancers like lung, liver, and colorectal cancer, and the management of treatment-related adverse events.
AI-summarised from recent articles · verify on publisher page →
General Information
Country / RegionSingapore
Primary LanguageEnglish
1st Year Published—
StatusActive
Total Publications—
Publisher OrgSpringer Science+Business Media
Submission Info
Peer ReviewAnonymous peer review
Review Time—
Acceptance Rate—
OA LicenseCC BY
OA Rate—
Ethics & Quality
COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Think.Check.Submit Compliance
8/12 · 67%
✅
Do you know the journal / publisher?
✅
Does the journal have a website?
✅
Is the ISSN verified?
✅
Indexed in a trusted database?
✅
Peer review process documented?
❌
Follows ethical publishing standards (COPE)?
❌
APC fees clearly disclosed?
✅
Not on predatory/blacklists?
❌
Long-term digital preservation?
❌
Plagiarism detection in place?
✅
Listed in DOAJ (verified OA)?
✅
Primary language documented?
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
Cancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsLung Cancer Treatments and MutationsFerroptosis and cancer prognosisCAR-T cell therapy researchLung Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisImmunotherapy and Immune ResponsesRNA modifications and cancerCancer-related molecular mechanisms research
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref